Used in biomedical research to quantify levels of human α2-antiplasmin in plasma or serum samples. This assay helps assess fibrinolytic system activity, particularly in studies related to thrombosis, bleeding disorders, and liver disease. Commonly applied in clinical laboratories and research settings to investigate the role of α2-antiplasmin in hemostasis and to evaluate its concentration changes under pathological conditions. The kit enables high-throughput, accurate measurement using a 96-well plate format, supporting investigations into antifibrinolytic therapy and coagulation regulation.